Concepedia

Veronika Matušková

VM

5

Publications

167

Citations

5

H-Index

2017

Active since

Affiliations

University Hospital Brno(Current)

Masaryk University

Charles University

Czech Academy of Sciences, Institute of Animal Physiology and Genetics

University of Ulsan

Veronika Matušková is an author at University Hospital Brno.

Publications per year

2017–2021

5

Publications

5

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration

Se Joon Woo, Miroslav Veith, Jan Hamouz et al. · JAMA Ophthalmology · 2020 · 75 citations · Full text

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

Neil M. Bressler, Miroslav Veith, Jan Hamouz et al. · British Journal of Ophthalmology · 2021 · 39 citations · Full text

An association of neovascular age‐related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population

Veronika Matušková, Tomáš Zeman, Laura Ewerlingová et al. · Acta Ophthalmologica · 2020 · 22 citations · Full text

Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes

Veronika Matušková, Daniela Vysloužilová, Michal Uher · Seminars in Ophthalmology · 2017 · 20 citations

<i>CD36</i> gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: Implications for the safety of the therapy

Veronika Matušková, Vladimír J. Balcar, Naim Akhtar Khan et al. · Ophthalmic Genetics · 2017 · 11 citations

Rows per page

1–5 of 5